Matthew J. Zimpfer - 19 Feb 2025 Form 4/A - Amendment Insider Report for CNO Financial Group, Inc. (CNO)

Role
General Counsel
Signature
Heidi M. Krings, Attorney-in-Fact
Issuer symbol
CNO
Transactions as of
19 Feb 2025
Net transactions value
-$1,910,974
Form type
4/A - Amendment
Filing time
24 Feb 2025, 17:48:12 UTC
Date Of Original Report
21 Feb 2025
Previous filing
13 Feb 2025
Next filing
27 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNO Common Stock Options Exercise $709,104 +40,800 +14% $17.38 326,543 19 Feb 2025 Direct
transaction CNO Common Stock Sale $1,692,898 -40,800 -12% $41.49 285,743 19 Feb 2025 Direct F1, F2
transaction CNO Common Stock Options Exercise $709,104 +40,800 +14% $17.38 326,543 21 Feb 2025 Direct
transaction CNO Common Stock Sale $1,636,284 -40,800 -12% $40.10 285,743 21 Feb 2025 Direct F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNO Employee Stock Option (Right to Buy) Options Exercise $0 -40,800 -50% $0.000000 40,800 19 Feb 2025 Common Stock 81,600 $17.38 Direct F5
transaction CNO Employee Stock Option (Right to Buy) Options Exercise $0 -40,800 -100% $0.000000 0 21 Feb 2025 Common Stock 40,800 $17.38 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan adopted on August 23, 2024.
F2 Reflects the weighted average sale price. Shares were sold at prices ranging from $41.20 per share to $41.80 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
F3 Reflects the weighted average sale price. Shares were sold at prices ranging from $39.66 per share to $41.00 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
F4 This amendment corrects (i) the presentation of the exercise of stock options and (ii) the amount of securities beneficially owned following the transactions.
F5 One-half of the stock options vested on February 23, 2018, and one-half vested on February 23, 2019.